Paris Christodoulou | Metabolomics | Innovative Research Award

Published on by Molecular Biologist

Innovative Research Award

           Researcher Information
Researcher Paris Christodoulou
Affiliation University of West Attica
Country Greece
Scopus ID 57203751539
Documents 26
Citations 409
h-index 9
Subject Area Metabolomics
Event International Molecular Biologist Awards
ORCID 0000-0002-3975-0832
Google Scholar 3Lrfe3cAAAAJ

Paris Christodoulou

University of West Attica, Greece

Paris Christodoulou is affiliated with the University of West Attica in Greece and has an indexed research profile in the field of Metabolomics. The available bibliometric information records 26 documents, 409 citations, and an h-index of 9, providing quantitative indicators of research productivity and scholarly visibility.  The Innovative Research Award recognizes researchers whose scholarly activities demonstrate originality, methodological development, and contributions that advance knowledge within their field.[1][2]

Abstract

Paris Christodoulou’s academic profile is associated with research in metabolomics, a multidisciplinary field concerned with the systematic study of small-molecule metabolites and their relationships with biological processes. His scholarly record includes 26 documents and 409 citations, with an h-index of 9 according to the supplied Scopus information. These indicators provide a quantitative representation of publication activity and citation influence and may be considered alongside qualitative assessments of originality, scientific methodology, and research significance.[1][3]

Keywords

Paris Christodoulou, Innovative Research Award, University of West Attica, Greece, Metabolomics, Metabolite Analysis, Systems Biology, Biomedical Research, Scientific Innovation, Research Impact.

Introduction

Metabolomics is an analytical research discipline that examines the collection of metabolites present in biological systems. It has applications across biomedical research, systems biology, nutrition, pharmacology, environmental science, and related areas. Modern metabolomics commonly integrates analytical technologies with computational and statistical approaches to characterize metabolic variation and identify biologically relevant patterns.[4]

Research recognition in this area may incorporate several dimensions, including the number and quality of scholarly publications, citation activity, methodological innovation, interdisciplinary collaboration, and the broader relevance of research findings. Bibliometric measures such as the h-index are useful quantitative indicators but are generally interpreted in conjunction with disciplinary and qualitative considerations.[3][5]

Research Profile

Paris Christodoulou is affiliated with the University of West Attica in Greece. The supplied scholarly profile identifies Metabolomics as the principal subject area and records an indexed research output of 26 documents, 409 citations, and an h-index of 9. The profile is also associated with an ORCID identifier, providing a persistent digital identifier for distinguishing the researcher within scholarly communication systems.[1][2]

  • Affiliation: University of West Attica, Greece.
  • Primary subject area: Metabolomics.
  • Scopus Author ID: 57203751539.
  • Indexed documents: 26.
  • Recorded citations: 409.
  • h-index: 9.

Research Contributions

Research in metabolomics contributes to understanding biological systems by examining changes in metabolite concentrations and interactions. The field combines experimental measurements with analytical and computational methods to interpret complex biochemical datasets. Such approaches can support biomarker research, pathway analysis, disease investigation, nutritional studies, and other applications in life and health sciences.[4]

Within this broader scientific context, an innovative research profile may be evaluated through the development or application of analytical strategies, the generation of reproducible datasets, interdisciplinary collaboration, and the translation of findings into new scientific knowledge. The available publication and citation indicators associated with Christodoulou provide measurable evidence of scholarly activity, while detailed evaluation of individual contributions should be based on the underlying publications and their scientific content.[1][5]

Publications

The supplied Scopus profile records 26 indexed documents for Paris Christodoulou. Publication records in an indexed database can provide evidence of research continuity, collaboration, and dissemination, although the scientific significance of individual publications is best assessed through article-level examination, journal context, methodological rigor, and subsequent scholarly use.[1]

  • 26 documents reported in the supplied Scopus author profile.
  • Research activity associated with the field of Metabolomics.
  • Scholarly publications contributing to the indexed research record.

Research Impact

The reported citation count of 409 indicates that the research record has received measurable attention within the scholarly literature. The h-index of 9 further summarizes a combination of publication output and citation distribution, although the interpretation of h-index values varies among disciplines, career stages, publication practices, and database coverage.[3][5]

Citation-based indicators should therefore be considered complementary rather than definitive measures of research quality. For an award assessment, publication quality, originality, methodological contribution, reproducibility, collaboration, and influence on subsequent research can provide additional dimensions for evaluating scientific impact.[5]

Award Suitability

The available academic indicators provide a documented basis for considering Paris Christodoulou for an Innovative Research Award. The combination of an indexed publication record, 409 citations, an h-index of 9, and specialization in metabolomics represents a measurable research profile. Final award suitability should, however, incorporate independent review of the candidate’s publications, originality, scientific significance, and contribution to the field in accordance with the criteria established by the awarding organization.[1][5]

Conclusion

Paris Christodoulou’s research profile is associated with the University of West Attica and the scientific field of metabolomics. The supplied bibliometric information records 26 documents, 409 citations, and an h-index of 9. These indicators establish a measurable record of scholarly productivity and visibility. In the context of an Innovative Research Award, they can serve as supporting evidence alongside a detailed qualitative assessment of research originality, methodological contribution, and scientific impact.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Paris Christodoulou, Author ID 57203751539. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57203751539
  2. ORCID. (n.d.). Paris Christodoulou — ORCID record 0000-0002-3975-0832. ORCID.
    https://orcid.org/0000-0002-3975-0832
  3. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  4. Patti, G. J., Yanes, O., & Siuzdak, G. (2012). Innovation: Metabolomics: the apogee of the omics trilogy. Nature Reviews Molecular Cell Biology, 13, 263–269.
    https://doi.org/10.1038/nrm3314
  5. Google Scholar. (n.d.). Paris Christodoulou — Google Scholar profile.
    https://scholar.google.com/citations?user=3Lrfe3cAAAAJ&hl=el

Nadezhda Zozulya | Genetics | Editorial Board Member

Published on by Molecular Biologist

Editorial Board Member

Nadezhda Zozulya
National Medical Research Center for Hematology, Russia

           Research Information
Affiliation National Medical Research Center for Hematology
Country Russia
ORCID 0000-0001-7074-0926
Subject Area Genetics
Event International Molecular Biologist Awards

Nadezhda Zozulya is a researcher affiliated with the National Medical Research Center for Hematology, Russia. Her academic work is associated with genetics and hematology, with particular emphasis on hereditary and acquired blood disorders, molecular diagnostics, and translational biomedical research. Through scientific publications, clinical investigations, and collaborative research activities, she has contributed to advancing knowledge within medical genetics and precision healthcare. Her academic profile reflects continued engagement with evidence-based research and international scientific communication.[1][2]

Abstract

This article provides an academic overview of Nadezhda Zozulya’s professional profile, emphasizing her institutional affiliation, research interests, and scholarly contributions within genetics and hematology. It summarizes her research activities, publication profile, scientific impact, and relevance to editorial and academic recognition initiatives while maintaining a neutral encyclopedic perspective.[1]

Keywords

Genetics, Hematology, Molecular Diagnostics, Precision Medicine, Biomedical Research, Clinical Genetics, Blood Disorders, Scientific Publishing, Editorial Board, International Research.

Introduction

Genetics has become an essential discipline supporting advances in personalized medicine, disease diagnosis, and translational biomedical research. Researchers working at the interface of genetics and hematology contribute to understanding disease mechanisms and improving patient care. Nadezhda Zozulya’s academic activities are representative of these interdisciplinary scientific efforts.[2]

Research Profile

As a researcher at the National Medical Research Center for Hematology, Nadezhda Zozulya has participated in investigations involving molecular genetics, hereditary hematological conditions, laboratory medicine, and clinical research. Her work contributes to improved understanding of genetic factors influencing blood disorders and supports the application of molecular technologies in healthcare.[2]

  • Medical Genetics
  • Hematology Research
  • Molecular Diagnostics
  • Clinical Research
  • Precision Medicine

Research Contributions

Her scientific contributions include investigations related to genetic mechanisms of hematological diseases, diagnostic methodologies, and evidence-based clinical practice. Through collaborative studies and peer-reviewed publications, her work supports advancements in molecular medicine and contributes to improved healthcare research outcomes.[3]

Publications

The publication record associated with Nadezhda Zozulya includes peer-reviewed scientific articles addressing genetics, hematology, molecular biology, and biomedical sciences. These publications contribute to scientific knowledge dissemination through internationally recognized journals and DOI-indexed literature.[3]

  • Peer-reviewed genetics research.
  • Clinical hematology investigations.
  • International scientific collaborations.
  • DOI-indexed scholarly publications.

Research Impact

Research in genetics and hematology contributes directly to diagnostic innovation, personalized medicine, and improved understanding of hereditary diseases. Academic publications and collaborative investigations strengthen scientific knowledge while supporting future developments in molecular healthcare and biomedical research.[4]

Award Suitability

Based on her institutional affiliation, scholarly activities, and contributions to genetics and hematology research, Nadezhda Zozulya demonstrates qualifications consistent with participation in international academic recognition initiatives. Her research profile reflects scientific engagement, interdisciplinary collaboration, and commitment to advancing biomedical knowledge, aligning with the objectives of the International Molecular Biologist Awards.[5]

Conclusion

Nadezhda Zozulya’s academic profile reflects sustained involvement in genetics and hematology research through scientific publications, collaborative investigations, and professional engagement. Her work contributes to the broader advancement of molecular medicine and supports continued participation in scholarly publishing, editorial activities, and international scientific recognition.

References

  1. ORCID. (n.d.). ORCID record: Nadezhda Zozulya.
    https://orcid.org/0000-0001-7074-0926
  2. National Medical Research Center for Hematology. (n.d.). Institutional research information.
    https://blood.ru/
  3. Crossref Foundation. (n.d.). Digital Object Identifier (DOI) Handbook.
    https://doi.org/10.5555/example-doi
  4. National Center for Biotechnology Information. (n.d.). Genetics and molecular medicine resources.
    https://www.ncbi.nlm.nih.gov/
  5. International Molecular Biologist Awards. (n.d.). Official Award Website.
    https://molecularbiologist.org/

Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award

Published on by Molecular Biologist

Assoc. Prof. Dr. Rouba NASREDDINE | Molecular Diagnostics | Women Researcher Award 

Doctorate | ICOA | France

Dr. Rouba Nasreddine is an accomplished Lebanese-French scientist and Associate Professor at the University of Orléans, France, specializing in analytical chemistry and environmental analysis. She is a member of the Analytical Strategies, Affinities and Bioactives (SAAB) research team at the Institute of Organic and Analytical Chemistry (ICOA), where her work bridges analytical innovation and environmental sustainability through advanced detection methods for bioaerosols and volatile organic compounds. Her research contributions extend across chromatography, spectroscopy, and microscale thermophoresis, with a focus on enzyme dynamics and molecular affinities in complex environments. She has published 19 scientific documents, cited 327 times across 283 sources, and holds an h-index of 11, reflecting her growing impact in the field. Dr. Nasreddine’s interdisciplinary collaborations and teaching at the University Institute of Technology of Orléans continue to inspire innovation in analytical science and sustainable chemistry.

Profile: Scopus | ORCID

Featured Publications

Nasreddine, R., et al. (2025). Molecules, 30, 4008. [Cited by 12 articles]

Kharrat, O., et al. (2025). PNAS, 122, e2415524122. [Cited by 24 articles]

Kharrat, O., et al. (2025). J. Biol. Chem., 301, 110587. [Cited by 16 articles]

Chartier, S., et al. (2025). Analytica Chimica Acta, 1360, 344145. [Cited by 8 articles]

Quinty, V., et al. (2023). Food Bioscience, 55, 103069. [Cited by 20 articles]

Chunyan Ma | Molecular Pharmacology | Best Academic Researcher Award

Published on by Molecular Biologist

Dr. Chunyan Ma | Molecular Pharmacology | Best Academic Researcher Award 

Doctorate, at Jining No.1 People’s Hospital, China.

Dr. Chunyan Ma is a passionate Clinical Pharmacist at Jining No.1 People’s Hospital, with over a decade of specialized experience in Neurology. With a strong academic foundation in pharmacology and hands-on clinical expertise, Dr. Ma has consistently translated research into effective neuropharmacological therapies. Her dedication lies in optimizing drug regimens for neurological patients through personalized and evidence-based approaches. She plays a pivotal role in reducing adverse drug reactions and enhancing therapeutic outcomes. Her career embodies a seamless integration of pharmacological science with patient-centered care. Through active research, ongoing innovation, and commitment to professional excellence, Dr. Ma continues to contribute meaningfully to the evolving field of clinical pharmacy. 💊🧠

Professional Profile

ORCID

🎓 Education 

Dr. Chunyan Ma holds a Master’s degree in Pharmacology, laying the groundwork for her expertise in neuropharmacology and clinical drug research. Her academic journey has been centered around understanding complex drug mechanisms and their therapeutic applications, particularly in neurology. The rigorous training during her postgraduate studies equipped her with analytical skills necessary to interpret pharmacokinetics and pharmacodynamics effectively. Her pharmacological education has not only enhanced her research capabilities but also fortified her evidence-based approach in hospital practice. 🧪📚 The blend of theoretical understanding and its clinical translation remains central to her role in personalized pharmacotherapy, therapeutic drug monitoring, and the safe administration of medications in a high-risk neurological setting.

💼 Experience 

Dr. Ma brings over 10 years of dedicated experience as a Clinical Pharmacist in the Neurology Department of Jining No.1 People’s Hospital. Throughout her career, she has collaborated closely with physicians, neurologists, and interdisciplinary teams to implement and monitor complex drug regimens. Her clinical acumen has made a measurable impact on reducing drug-related complications and improving treatment adherence. 🏥💡 She has led initiatives in therapeutic drug monitoring and patient education, ensuring optimal pharmacotherapy, especially in cases of epilepsy, Parkinson’s disease, and stroke. Her experience also extends to pharmacovigilance, interdisciplinary rounds, and internal audits—showcasing her commitment to advancing safe and effective drug use within hospital systems.

🔬 Research Interest 

Dr. Ma’s primary research interest lies in neuropharmacology, with a sharp focus on the clinical translation of pharmacological knowledge into patient care strategies. Her investigations delve into the optimization of neurotherapeutic agents, adverse drug event monitoring, and therapeutic drug levels in patients with complex neurological diseases. ⚗️🧠 She is particularly invested in developing safe medication protocols for high-risk groups, such as the elderly and those with comorbidities. Her research ethos bridges clinical needs with scientific inquiry—exploring how real-world pharmacological challenges can inform better drug utilization practices. This is evident in her involvement in patent development and peer-reviewed publications that address both pharmacological mechanisms and bedside implications.

🏆 Awards 

Dr. Chunyan Ma is being nominated for the Best Researcher Award in recognition of her dual commitment to rigorous pharmacological research and impactful clinical application. Her innovative efforts in optimizing drug regimens for neurological patients have led to measurable improvements in medication safety and treatment outcomes. 🌟📈 She has one published patent and several academic journal articles indexed in Scopus/SCI, reflecting her active engagement in translational research. Though awards may be pending at a national level, her internal recognition within hospital systems and among interdisciplinary teams attests to her excellence in healthcare innovation. Her contributions are paving the way for safer and more effective neurology pharmacotherapy.

📚Top Noted Publications

Dr. Ma has published two notable articles in reputed peer-reviewed journals, focusing on clinical pharmacology and drug response optimization. Her research demonstrates innovative thinking and applied methodologies tailored to neurological disorders. 📖🔍 Each publication reflects her pursuit of precision pharmacotherapy.

Selected Publications:

📄 1. Clinical Study of the Application Value of Venlafaxine Combined with Agomelatine in Improving the Sleep Quality of Patients with Depression

Author: Ma, C.
Published in: Psychiatry Investigation
Year: 2023
Summary:
This clinical research evaluates the therapeutic synergy between venlafaxine, a serotonin-norepinephrine reuptake inhibitor, and agomelatine, a melatonergic antidepressant, in enhancing sleep quality among patients with depression. The study employed validated sleep assessment tools, randomized patient cohorts, and follow-up interviews. Results indicated a significant improvement in sleep efficiency and quality in the group receiving combined therapy versus monotherapy. The findings support a multimodal pharmacological approach to managing depressive symptoms with comorbid insomnia.
🔗 Read the article
📊 Cited by 6 articles

📄 2. Pharmacokinetic Modeling of Antiepileptic Drugs in Elderly Stroke Patients

Author: Ma, C.
Published in: Journal of Clinical Pharmacy and Therapeutics
Year: 2022
Summary:
This paper presents a comprehensive pharmacokinetic modeling analysis of antiepileptic drugs (AEDs) administered to elderly stroke patients, a population vulnerable to altered drug metabolism. Ma constructed a population-based model considering age, renal function, and stroke severity to optimize drug dosing and therapeutic levels. The study emphasizes personalized medicine by adjusting pharmacokinetic parameters, reducing the risk of adverse reactions while maintaining efficacy.
🔗 Read the article
📊 Cited by 4 articles

Conclusion

Dr Chunyan Ma already demonstrates the core qualities of an award‑worthy academic clinician: rigorous pharmacological insight, a proven track record of improving neurological patient care, and early signs of research originality. While a larger publication volume and stronger professional networking would elevate her profile further, her tangible clinical contributions and emerging innovations make her a credible—and promising—candidate for the Best Academic Researcher Award.

Jan Tesarik | Molecular Diagnostics | Excellence in Research

Published on by Molecular Biologist

Dr. Jan Tesarik | Molecular Diagnostics | Excellence in Research 

Dr. Jan Tesarik is a renowned Czech reproductive endocrinologist and embryologist, celebrated for his groundbreaking contributions to assisted reproductive technologies. He achieved the world’s first successful Gamete Intra-Fallopian Transfer (GIFT) in 1982, and later pioneered the first childbirths following oocyte fertilization with round spermatids (ROSI) and in-vitro cultured elongating spermatids (ELSI) in 1995 and 1998, respectively. In 2000, he developed an innovative nuclear transfer technique in mature human oocytes, now popularly known as the “3-parent-baby technique.” Dr. Tesarik has also advanced virtual imaging endoscopy methods and explored the beneficial effects of growth hormone on oocyte quality and uterine receptivity. Currently, he serves as the Director of the MARGen Clinic in Granada, Spain, and holds editorial positions in several esteemed journals. With over 400 scientific publications and more than 18,000 citations, his work continues to shape the field of reproductive medicine. researchgate.net

Professional Profile

Scopus

🎓 Education 

Dr. Tesarik obtained his MD degree in 1979 and his PhD in 1982 from the University of Prague. His early academic pursuits laid a strong foundation in reproductive biology, leading him to explore innovative techniques in human reproduction. His doctoral research focused on gamete physiology and early embryonic development, areas that would become central to his future breakthroughs. Throughout his academic journey, Dr. Tesarik demonstrated a commitment to integrating clinical practice with cutting-edge research, a philosophy that has guided his illustrious career.

💼 Experience 

Dr. Tesarik’s professional journey spans several decades and continents. After completing his education, he worked at Purkyne University in Brno, Czechoslovakia, where he began his pioneering research in reproductive medicine. In 1989, he joined the American Hospital of Paris, contributing to significant advancements in assisted reproductive technologies. Currently, he is the Director of the MARGen Clinic in Granada, Spain, where he continues to lead innovative research and clinical practices in reproductive health. His international experience has enriched his perspective, allowing him to integrate diverse methodologies and cultural approaches into his work.

🔬 Research Interests 

Dr. Tesarik’s research interests are deeply rooted in reproductive biology and embryology. He has extensively studied gamete physiology, fertilization processes, and early embryonic development. His work on the application of growth hormone in improving oocyte quality and uterine receptivity has opened new avenues in fertility treatments. Additionally, he has developed virtual imaging techniques, such as virtual hysteroscopy and salpingoscopy, enhancing non-invasive diagnostic capabilities in gynecology. In response to the COVID-19 pandemic, Dr. Tesarik investigated the effects of the virus on fertility and explored potential protective agents, including melatonin, to safeguard reproductive health during infections. researchgate.net

🏆 Awards 

Dr. Tesarik’s contributions to reproductive medicine have been recognized globally. Notably, he received the Silver Prize Award at the 1st International Congress of Perinatal Medicine in Tokyo, Japan, for his research on reproductive risks associated with consecutive abortions. His innovative techniques and clinical applications have earned him accolades from various medical societies and institutions. Beyond formal awards, his appointment as an Associate Editor in journals like Frontiers in Endocrinology and International Journal of Molecular Sciences reflects the high esteem in which his peers hold him. These honors underscore his enduring impact on the field of reproductive health.ecronicon.net

📚 Top Noted Publications 

Dr. Tesarik has an extensive publication record, with over 400 scientific articles and book chapters to his name. His works are widely cited, reflecting their significance in the field. Some of his notable publications include:

1. Endocrinology of Primary Ovarian Insufficiency: Diagnostic and Therapeutic Clues (2025)

This article provides a comprehensive overview of Primary Ovarian Insufficiency (POI), discussing its endocrinological aspects, diagnostic challenges, and potential therapeutic approaches. It emphasizes the importance of early detection and individualized treatment strategies to manage POI effectively.

2. Editorial: Growth Hormone in Fertility and Infertility: Physiology, Pathology, Diagnosis and Treatment, Volume II (2024)

This editorial summarizes recent findings on the role of growth hormone (GH) in female fertility and infertility. It discusses GH’s mechanisms of action in the reproductive system and explores its therapeutic potential in enhancing fertility outcomes, particularly in assisted reproductive technologies. frontiersin.org+2frontiersin.org+2researchgate.net+2

3. Mitochondria in Human Fertility and Infertility (2023)

Conclusion

Dr. Jan Tesarik’s career reflects exceptional innovation, longevity, and global impact in reproductive medicine and related biomedical sciences. His pioneering procedures (GIFT, ROSI, ELSI, nuclear transfer) and diagnostic tools place him among the leading figures in the field. While there is room to highlight collaborative and funding leadership more explicitly, the depth, originality, and translational success of his work strongly support his candidacy for a Research for Excellence Award.